SubHero Banner
Text

March 2019

Core topics in this month’s edition include:

  • Mayzent (siponimod) – new drug approval
  • Losartan- and valsartan-containing product recalls
  • American College of Cardiology and American Heart Association – Primary Prevention of Cardiovascular Disease

Download PDF

Text